Subcutaneous continuous erythropoietin receptor activator conversion provides practical advantages and potential convenience for peritoneal dialysis patients

Perit Dial Int. 2011 Sep-Oct;31(5):592-5. doi: 10.3747/pdi.2011.00013.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Anemia / etiology
  • Anemia / prevention & control*
  • Erythropoietin / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis* / adverse effects
  • Polyethylene Glycols / administration & dosage*
  • Prospective Studies

Substances

  • continuous erythropoietin receptor activator
  • Erythropoietin
  • Polyethylene Glycols